Back

Prognostic significance of endogenous-type coronary microvascular dysfunction following elective percutaneous coronary intervention

31 August 2025 (17:15 - 18:00)
Organised by: Logo
Congress Presentation Part of: Advances in intracoronary physiology Intracoronary Flow and Pressure Measurements ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Takahiro Watanabe

Tsuchiura Kyodo General Hospital, Tsuchiura (Japan)

7 More presentations in this session

Presentation thumbnail
The prognostic significance of microvascular resistance reserve: a systematic review and meta-analysis
Doctor N. Pyrpyris (Athens, GR)
Abstract Slides Video
Presentation thumbnail
Impact of sex on residual angina stratified by pathophysiological disease pattern
Doctor M. Hada (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Invasive central aortic pressure waveform analysis in relation to thermodilution-derived coronary flow indices and major cardiovascular events in chronic coronary syndrome
Doctor R. Kader (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Impact of age and sex in coronary microvascular function in patients with angina and nonobstructive coronary arteries
Doctor S. Kostantinis (New Haven, US)
Abstract Slides Video
Presentation thumbnail
Thresholds of invasive physiological indices associated with angina and limited exercise capacity in patients with chronic coronary syndrome: SYMPTOM registry
Miss N. Higashimoto (Wakayama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Advances in intracoronary physiology

The Event

Event poster

ESC Congress 2025

31 August 2025 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Coronary microvascular dysfunction endotypes and clinical outcomes in patients with ischemia and no obstructive coronary arteries: A meta-analysis
thumbnail
Congress Presentation
Invasive assessment of coronary microvascular dysfunction with MACEs: a meta-analysis
thumbnail
Congress Session
Atypical coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources